Epilepsy across the spectrum: Promoting health and understanding. A summary of the Institute of Medicine report

Epilepsy and Behavior

Volumn 25, Issue 2, 2012, Pages 266-276

  England, Mary Jane ^a   Liverman, Catharyn T ^b   Schultz, Andrea M ^b   Strawbridge, Larisa M ^b  

^a BOSTON UNIVERSITY   (United States)

^b Institute of Medicine   (United States)

Author keywords

Education; Epilepsy; Health care; Health policy; Public health; Quality of life; Stigma; Surveillance

Indexed keywords

ACCREDITATION; AWARENESS; DRIVING ABILITY; EMPLOYMENT; EPILEPSY; FAMILY; FEASIBILITY STUDY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; PATIENT EDUCATION; QUALITY OF LIFE; REVIEW; SCHOOL; SOCIAL ASPECT; SOCIAL WELFARE; UNITED STATES;

ACADEMIES AND INSTITUTES; EPILEPSY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PUBLIC HEALTH; QUALITY OF LIFE; SOCIAL STIGMA; UNITED STATES;

EID: 84867919638     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.06.016     Document Type: Review

References (45)

1. IOM Epilepsy across the spectrum: promoting health and understanding 2012, The National Academies Press, Washington, DC.
2. Hauser W.A., Annegers J.F., Elveback L.R. Mortality in patients with epilepsy. Epilepsia 1980, 21(4):399-412.
3. Thurman D. Epidemiologic research and surveillance of the epilepsies: a systems-level perspective PowerPoint presented at the IOM meeting on public health dimensions of the epilepsies, Washington, DC, January 10. Available from:. http://iom.edu/~/media/Files/Activity%20Files/Disease/Epilepsy/Thurman%202.pdf.
4. Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007, 68(5):326-337.
5. Hesdorffer D.C., Logroscino G., Benn E.K.T., Katri N., Cascino G., Hauser W.A. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology 2011, 76(1):23-27.
6. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342(5):314-319.
7. Yoon D., Frick K.D., Carr D.A., Austin J.K. Economic impact of epilepsy in the United States. Epilepsia 2009, 50(10):2186-2191.
8. Begley C.E., Famulari M., Annegers J.F., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41(3):342-351.
9. Forsgren L., Hauser W.A., Olafsson E., Sander J.W.A.S., Sillanpää M., Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia 2005, 46(Suppl. 11):18-27.
10. Tomson T., Beghi E., Sundqvist A., Johannessen S.I. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 2004, 60(1):1-16.
11. Gaitatzis A., Johnson A.L., Chadwick D.W., Shorvon S.D., Sander J.W. Life expectancy in people with newly diagnosed epilepsy. Brain 2004, 127(Pt. 11):2427-2432.
12. Tomson T., Nashef L., Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 2008, 7(11):1021-1031.
13. Bandstra N.F., Camfield C.S., Camfield P.R. Stigma of epilepsy. Can J Neurol Sci 2008, 35(4):436-440.
14. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
15. NINDS Epilepsy research benchmarks progress update (2007-2009) Available from:. http://www.ninds.nih.gov/research/epilepsyweb/2010_benchmarks.pdf.
16. Trevathan E. "Flying blind" without epilepsy surveillance data. Neurology 2011, 76(1):10-11.
17. Del Brutto O.H. Neurocysticercosis: a review. Scientific World Journal 2012, 2012:159821.
18. Ong S., Talan D.A., Moran G.J., et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002, 8(6):608-613.
19. Serpa J.A., Graviss E.A., Kass J.S., White A.C. Neurocysticercosis in Houston, Texas: an update. Medicine 2011, 90(1):81-86.
20. Sorvillo F., Wilkins P., Shafir S., Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011, 17(1):1-6.
21. Wallin M.T., Kurtzke J.F. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004, 63(9):1559-1564.
22. White A.C. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 2000, 51:187-206.
23. Carpio A., Escobar A., Hauser W.A. Cysticercosis and epilepsy: a critical review. Epilepsia 1998, 39(10):1025-1040.
24. Sotelo J. Clinical manifestations, diagnosis, and treatment of neurocysticercosis. Curr Neurol Neurosci Rep 2011, 11(6):529-535.
25. Hesdorffer D.C., Tomson T., Benn E., et al. Combined analysis of risk factors for SUDEP. Epilepsia 2011, 52(6):1150-1159.
26. Hitiris N., Suratman S., Kelly K., Stephen L.J., Sills G.J., Brodie M.J. Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav 2007, 10(1):138-141.
27. Langan Y., Nashef L., Sander J.W. Case-control study of SUDEP. Neurology 2005, 64(7):1131-1133.
28. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 1999, 353(9156):888-893.
29. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001, 56(4):519-525.
30. Begley C.E., Basu R., Reynolds T., et al. Sociodemographic disparities in epilepsy care: results from the Houston/New York City health care use and outcomes study. Epilepsia 2009, 50(5):1040-1050.
31. Elliott J.O., Lu B., Shneker B.F., Moore J.L., McAuley J.W. The impact of 'social determinants of health' on epilepsy prevalence and reported medication use. Epilepsy Res 2009, 84(2-3):135-145.
32. Burneo J.G., Black L., Knowlton R.C., Faught E., Morawetz R., Kuzniecky R.I. Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology 2005, 64(1):50-54.
33. Chappell B., Smithson H. Meeting the educational needs of general practitioners for epilepsy. Seizure 1999, 8(3):157-162.
34. Elliott J., Shneker B. Patient, caregiver, and health care practitioner knowledge of, beliefs about, and attitudes toward epilepsy. Epilepsy Behav 2008, 12(4):547-556.
35. Gomes M.D. Doctors' perspectives and practices regarding epilepsy. Arq Neuropsiquiatr 2000, 58(2A):221-226.
36. Hayes S.M., Melin J.D., Dupuis M., Murray S., Labiner D.M. Assessing the true learning needs of health care professionals in epilepsy care. Epilepsy Behav 2007, 11(3):434-441.
37. Bishop M., Allen C. Coping with epilepsy: research and intervention. Coping with chronic illness and disability: theoretical, empirical, and clinical aspects 2007, 241-266. Springer Publishing Co., New York. E. Martz, H. Livneh (Eds.).
38. Cochrane J. Patient education: lessons from epilepsy. Patient Educ Couns 1995, 26(1-3):25-31.
39. Caveness W.F., Gallup G.H. A survey of public attitudes toward epilepsy in 1979 with an indication of trends over the past thirty years. Epilepsia 1980, 21(5):509-518.
40. Jacoby A. Stigma, epilepsy, and quality of life. Epilepsy Behav 2002, 3(6S2):10-20.
41. Kobau R., Price P. Knowledge of epilepsy and familiarity with this disorder in the U.S. population: results from the 2002 HealthStyles Survey. Epilepsia 2003, 44(11):1449-1454.
42. Brown W.J., Basil M.D. Media celebrities and public health: responses to 'Magic' Johnson's HIV disclosure and its impact on AIDS risk and high-risk behaviors. Health Commun 1995, 7(4):345-370.
43. Casey M.K., Allen M., Emmers-Sommer T., et al. When a celebrity contracts a disease: the example of Earvin "Magic" Johnson's announcement that he was HIV positive. J Health Commun 2003, 8(3):249-265.
44. Cram P., Fendrick A.M., Inadomi J., Cowen M.E., Carpenter D., Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003, 163(13):1601-1605.
45. Beck C.S. Personal stories and public activism: the implications of Michael J. Fox's public health narrative for policy and perspectives. Health communication in practice: a case study approach 2005, 335-345. Lawrence Erlbaum Associates, Mahwah, NJ. E.B. Ray (Ed.).